Vyne Therapeutics Inc (VYNE) is a therapeutics company whose core business activity cannot be fully characterized from the available filing excerpts. The 10-K filed 2026-02-27 (accession 000156604426000002) provides only the cover-page boilerplate of the annual report for the fiscal year ended, with no substantive disclosure of products, revenue streams, pipeline, commercial operations, or financial results in the excerpts provided. Because the filing excerpts do not support specific claims about business model, revenue, products, customers, competitors, or geographic footprint, those details are omitted here in accordance with source-grounding requirements. Investors should consult the full 10-K filing directly for accurate business and financial information.

Source: SEC 10-K, filed 2026-02-27

Industry: Pharmaceutical Preparations Peers: Ampio Pharmaceuticals, Inc. TREX WIND-DOWN, INC. cbdMD Inc PLx Pharma Winddown Corp. Evofem Biosciences Inc Jaguar Health Inc Johnson & Johnson Unrivaled Brands, Inc. Weed Inc Virpax Pharmaceuticals, Inc.